| Name | Cevidoplenib dimesylate |
|---|
| Description | Cevidoplenib is an orally available inhibitor of spleen tyrosine kinase (Syk), with potential anti-inflammatory and immunomodulating activities[1][2]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C27H35N7O9S2 |
|---|---|
| Molecular Weight | 665.74 |